These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 33766042)
1. Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis. Chen Q; Qiu B; Zeng X; Hu L; Huang D; Chen K; Qiu X Cancer Cell Int; 2021 Mar; 21(1):182. PubMed ID: 33766042 [TBL] [Abstract][Full Text] [Related]
2. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Xu HH; Wang HL; Xing TJ; Wang XQ Front Immunol; 2022; 13():851622. PubMed ID: 35924232 [TBL] [Abstract][Full Text] [Related]
3. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma. Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188 [No Abstract] [Full Text] [Related]
4. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related]
5. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
6. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer. Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H Front Genet; 2022; 13():938250. PubMed ID: 36561319 [No Abstract] [Full Text] [Related]
7. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis. Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197 [TBL] [Abstract][Full Text] [Related]
8. Six-lncRNA Immune Prognostic Signature for Cervical Cancer. Chen Q; Hu L; Huang D; Chen K; Qiu X; Qiu B Front Genet; 2020; 11():533628. PubMed ID: 33173530 [TBL] [Abstract][Full Text] [Related]
9. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma. Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269 [TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients. Huang S; Zhang J; Lai X; Zhuang L; Wu J Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851 [No Abstract] [Full Text] [Related]
11. Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis. Chen Q; Hu L; Chen K Front Genet; 2020; 11():570325. PubMed ID: 33193668 [TBL] [Abstract][Full Text] [Related]
12. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer. Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681 [TBL] [Abstract][Full Text] [Related]
13. An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma. Yang H; Han X; Hao Z Front Mol Biosci; 2021; 8():679474. PubMed ID: 34291084 [No Abstract] [Full Text] [Related]
14. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Wu M; Li X; Zhang T; Liu Z; Zhao Y Front Oncol; 2019; 9():996. PubMed ID: 31612115 [No Abstract] [Full Text] [Related]
15. Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer. Wang X; Wang J; Yu M Comput Math Methods Med; 2022; 2022():1902289. PubMed ID: 35345518 [TBL] [Abstract][Full Text] [Related]
16. Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment. Liu Q; Bao H; Zhang S; Song T; Li C; Sun G; Sun X; Fu T; Wang Y; Liang P Front Genet; 2023; 14():1096792. PubMed ID: 36911393 [No Abstract] [Full Text] [Related]
17. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer. Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071 [TBL] [Abstract][Full Text] [Related]
18. A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer. Lin Y; Zhang R; Pan H; Li Y Med Sci Monit; 2023 Mar; 29():e938660. PubMed ID: 36973995 [TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration. Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559 [No Abstract] [Full Text] [Related]
20. Molecular subtypes and nomogram for predicting the prognosis of cervical cancer based on a matrix-immune signature. Liao Y; Huang Q; Shen G; Muhanmode Y; Luo X; Li F; Wen M; Liu J; Huang H Discov Oncol; 2024 Sep; 15(1):405. PubMed ID: 39230769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]